The Relative Strength (RS) Rating for Ingevity entered a new percentile Tuesday, as it got a lift from 69 to 75.
IBD's unique rating identifies price performance with a 1 (worst) to 99 (best) score. The rating shows how a stock's price performance over the trailing 52 weeks compares to all the other stocks in our database.
Over 100 years of market history shows that the stocks that go on to make the biggest gains often have an 80 or higher RS Rating in the early stages of their moves. See if Ingevity can continue to show renewed price strength and hit that benchmark.
When To Sell Stocks To Lock In Profits And Minimize Losses
Ingevity is working on a cup without handle with a 56.30 buy point. See if it can clear the breakout price in heavy trading.
Although earnings and sales growth came in at -9% and -15%, respectively, in the latest report, that means earnings have improved for the last three quarters and sales have increased for one.
The company earns the No. 19 rank among its peers in the Chemicals-Specialty industry group. Air Products & Chemicals, Cabot Corp and Element Solutions are among the top 5 highly rated stocks within the group.
RELATED:
Stocks With Rising Relative Strength Ratings
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
